Technology firm Kromek has reported a revenue increase for its full year.
For the period (end-30 April), the company posted revenue of €23.4 million, up 24% compared with €20.4 million last year. Net loss for the year was €4.2 million down from 2023's €7.7 million.
Kromek continues development of cadmium zinc telluride (CZT) detectors for photon counting CT and noted the launch of Spectrum Dynamics Medical's SPT/CT device Veriton-CT 300, which uses Kromek’s digital detectors, it said.
